Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis
- 1 March 2017
- journal article
- review article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 304, 93-96
- https://doi.org/10.1016/j.jneuroim.2016.12.003
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosisMultiple Sclerosis and Related Disorders, 2015
- Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomographyMultiple Sclerosis Journal, 2015
- Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's diseaseArchives of Gerontology and Geriatrics, 2015
- Longitudinal follow-up of vision in a neuromyelitis optica cohortMultiple Sclerosis Journal, 2013
- Association of Retinal and Macular Damage with Brain Atrophy in Multiple SclerosisPLOS ONE, 2011
- Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuityNeurology, 2010
- Reproducibility of Optical Coherence Tomography in Multiple SclerosisArchives of Neurology, 2008
- Quantifying axonal loss after optic neuritis with optical coherence tomographyAnnals of Neurology, 2006
- Multiple sclerosis: periphlebitis retinalis et cerebro-spinalis A correlation between periphlebitis retinalis and abnormal technetium brain scintigraphyActa Neurologica Scandinavica, 1984
- Insidious Atrophy of Retinal Nerve Fibers in Multiple SclerosisAmerican Journal of Ophthalmology, 1974